ŠPAČEK, M., P. OBRTLÍKOVÁ, Markéta HADRABOVÁ, Eduard CMUNT, J. KARBAN, J. MOLINSKÝ, M. SIMKOVIC, Heidi MÓCIKOVÁ, L. MOHAMMADOVA, Anna PANOVSKÁ, J. NOVÁK, Lukáš SMOLEJ, Michael DOUBEK a Marek TRNĚNÝ. Observational study in comorbid patients with CLL receiving first-line rituximab-bendamustine. In XVII International Workshop on Chronic Lymphocytic Leukemia. 2017. |
Další formáty:
BibTeX
LaTeX
RIS
@proceedings{1404124, author = {Špaček, M. and Obrtlíková, P. and Hadrabová, Markéta and Cmunt, Eduard and Karban, J. and Molinský, J. and Simkovic, M. and Móciková, Heidi and Mohammadova, L. and Panovská, Anna and Novák, J. and Smolej, Lukáš and Doubek, Michael and Trněný, Marek}, booktitle = {XVII International Workshop on Chronic Lymphocytic Leukemia}, keywords = {observational; CLL; study}, language = {eng}, title = {Observational study in comorbid patients with CLL receiving first-line rituximab-bendamustine}, year = {2017} }
TY - CONF ID - 1404124 AU - Špaček, M. - Obrtlíková, P. - Hadrabová, Markéta - Cmunt, Eduard - Karban, J. - Molinský, J. - Simkovic, M. - Móciková, Heidi - Mohammadova, L. - Panovská, Anna - Novák, J. - Smolej, Lukáš - Doubek, Michael - Trněný, Marek PY - 2017 TI - Observational study in comorbid patients with CLL receiving first-line rituximab-bendamustine KW - observational KW - CLL KW - study N2 - Observational study in comorbid patients with CLL receiving first-line rituximab-bendamustine, Observational study in comorbid patients with CLL receiving first-line rituximab-bendamustine ER -
ŠPAČEK, M., P. OBRTLÍKOVÁ, Markéta HADRABOVÁ, Eduard CMUNT, J. KARBAN, J. MOLINSKÝ, M. SIMKOVIC, Heidi MÓCIKOVÁ, L. MOHAMMADOVA, Anna PANOVSKÁ, J. NOVÁK, Lukáš SMOLEJ, Michael DOUBEK a Marek TRNĚNÝ. Observational study in comorbid patients with CLL receiving first-line rituximab-bendamustine. In \textit{XVII International Workshop on Chronic Lymphocytic Leukemia}. 2017.
|